Saneron CCEL Therapeutics, Inc.
Saneron is a biotechnology R&D company, focused on neurological and cardiac cell therapy for the early intervention and treatment of several devastating or deadly diseases, which lack adequate treatment options.
Saneron, a University of South Florida spin-out company is located at the Tampa Bay Technology Incubator. An affiliate of Cryo-Cell International, Inc.
Saneron is committed to providing readily available, non-controversial, ethically acceptable cells, both stem cells and other cell types, for cellular therapies. Saneron has patented and patent-pending technology relating to our platform technology of:
- U-CORD-CELL® - Umbilical cord blood
- SERT-CELLTM - Sertoli cells